Iofina (LON:IOF) Issues Earnings Results

Iofina (LON:IOFGet Free Report) announced its quarterly earnings results on Monday. The company reported GBX 1.80 earnings per share (EPS) for the quarter, Digital Look Earnings reports. Iofina had a return on equity of 15.30% and a net margin of 12.91%.

Iofina Stock Performance

LON IOF traded down GBX 0.10 on Thursday, reaching GBX 52.90. The stock had a trading volume of 313,558 shares, compared to its average volume of 547,194. The company has a debt-to-equity ratio of 10.80, a quick ratio of 1.56 and a current ratio of 2.57. Iofina has a 12-month low of GBX 20 and a 12-month high of GBX 60.12. The business’s 50-day moving average price is GBX 53.70 and its 200 day moving average price is GBX 44.92. The stock has a market cap of £101.49 million, a P/E ratio of 13.22 and a beta of 0.88.

Insider Activity

In other Iofina news, insider Tim Hughes bought 20,003 shares of the business’s stock in a transaction dated Monday, June 29th. The shares were acquired at an average cost of GBX 50 per share, with a total value of £10,001.50. Company insiders own 13.44% of the company’s stock.

Analyst Ratings Changes

Separately, Canaccord Genuity Group upped their target price on shares of Iofina from GBX 65 to GBX 70 and gave the company a “buy” rating in a report on Monday, September 14th. One research analyst has rated the stock with a Buy rating, Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and a consensus target price of GBX 70.

Get Our Latest Stock Report on Iofina

About Iofina

(Get Free Report)

Iofina plc is a vertically integrated company that specialises in the production of Iodine and the manufacturing of specialty chemical products and derivatives. Iofina is the second largest producer of iodine in North America and operates the manufacturing entities, Iofina Resources, and Iofina Chemical.

See Also

Receive News & Ratings for Iofina Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iofina and related companies with MarketBeat.com's FREE daily email newsletter.